Silver Grove Financial Group, Inc.

Position in HLN — Haleon plc

CIK 2111172 ORCHARD PARK, NY

Position in HLN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,572

New position

Shares Held

257

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Silver Grove Financial Group, Inc. holds $93,567 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	766	$90,548
2	HLN	Haleon plc This page	257	$2,572
3	BTAI	BioXcel Therapeutics, Inc.	334	$447

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,572	257	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.